51. MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View.
- Author
-
Bozzato AM, Martingano P, Pozzi Mucelli RA, Cavallaro MFM, Cesarotto M, Marcello C, Tiribelli C, Pascut D, Pizzolato R, Pozzi Mucelli F, Giuffrè M, Crocè LS, and Cova MA
- Abstract
Hepatocellular Carcinoma (HCC) is the sixth most common cancer in the world. Patients with intermediate stage (Barcelona Clinic Liver Cancer, B stage) hepatocellular carcinoma (HCC) have been able to benefit from TACE (transarterial chemoembolization) as a treatment option. MicroRNAs (miRNAs), i.e., a subclass of non-coding RNAs (ncRNAs), participate in post-transcriptional gene regulation processes and miRNA dysfunction has been associated with apoptosis resistance, cellular proliferation, tumor genesis, and progression. Only a few studies have investigated the role of miRNAs as biomarkers predicting TACE treatment response in HCC. Here, we review the studies' characteristics from a radiological point of view, also correlating data with radiological images chosen from the cases of our institution.
- Published
- 2022
- Full Text
- View/download PDF